title: Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by hyperthyroidism.
abstract: We report on a 74-year-old female patient with primary hemochromatosis complicated by hyperthyroidism. The serum ferritin level was reduced throughout a 217 day administration of deferoxamine (1 g/day). At the same time, the thyroid gland was changed from hyper- to hypo- functional proportionally.
authors.affiliation: Department of Medicine, Kusatsu Branch Hospital, Gunma University School of Medicine, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kubota
authors.forename: H
authors.initials: H
authors.lastname: Kurabayashi
authors.forename: J
authors.initials: J
authors.lastname: Tamura
authors.forename: E
authors.initials: E
authors.lastname: Kawada
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: K
authors.initials: K
authors.lastname: Nagashima
authors.forename: T
authors.initials: T
authors.lastname: Shirakura
mesh_terms: D000368:Aged; D003676:Deferoxamine / Q000627:therapeutic use; D005260:Female; D006432:Hemochromatosis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D011441:Propylthiouracil / Q000627:therapeutic use; D013960:Thyroid Function Tests
chemical_list: D011441:Propylthiouracil; D003676:Deferoxamine